Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (381-390 of 460) with videos related to

Pageof 46
Sort By:
Blood Advances|February 22, 2024
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemiaRegina M Myers, Kaitlin Devine, Yimei Li, et al.
Molecular Therapy Oncolytics|October 12, 2018
Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine GliomasYibo Yin, Alina C Boesteanu, Zev A Binder, et al.
Cell|October 5, 2023
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cellsConnor A Tsuchida, Nadav Brandes, Raymund Bueno, et al.
JCI Insight|May 10, 2022
A phase I trial of cyclosporine for hospitalized patients with COVID-19Emily A Blumberg, Julia Han Noll, Pablo Tebas, et al.
Nature|June 8, 2022
Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, Mikko Siurala, Leon L Su, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cellsConnor A Tsuchida, Nadav Brandes, Raymund Bueno, et al.
Nature|November 15, 2022
Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, Mikko Siurala, Leon L Su, et al.
Immunity|March 9, 2022
Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancersJosephine R Giles, Sasikanth Manne, Elizabeth Freilich, et al.
Blood Advances|November 19, 2019
CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapyVinodh Pillai, Kavitha Muralidharan, Wenzhao Meng, et al.
Cancer Discovery|February 1, 2020
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell DysfunctionNathan Singh, Yong Gu Lee, Olga Shestova, et al.
Pageof 46

Showing results (381-390 of 460) with videos related to

Sort By:
Pageof 46
Blood Advances|February 22, 2024
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemiaRegina M Myers, Kaitlin Devine, Yimei Li, et al.
Molecular Therapy Oncolytics|October 12, 2018
Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine GliomasYibo Yin, Alina C Boesteanu, Zev A Binder, et al.
Cell|October 5, 2023
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cellsConnor A Tsuchida, Nadav Brandes, Raymund Bueno, et al.
JCI Insight|May 10, 2022
A phase I trial of cyclosporine for hospitalized patients with COVID-19Emily A Blumberg, Julia Han Noll, Pablo Tebas, et al.
Nature|June 8, 2022
Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, Mikko Siurala, Leon L Su, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cellsConnor A Tsuchida, Nadav Brandes, Raymund Bueno, et al.
Nature|November 15, 2022
Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, Mikko Siurala, Leon L Su, et al.
Immunity|March 9, 2022
Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancersJosephine R Giles, Sasikanth Manne, Elizabeth Freilich, et al.
Blood Advances|November 19, 2019
CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapyVinodh Pillai, Kavitha Muralidharan, Wenzhao Meng, et al.
Cancer Discovery|February 1, 2020
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell DysfunctionNathan Singh, Yong Gu Lee, Olga Shestova, et al.
Pageof 46